研究者詳細 - 寺坂　友博

論文 - 寺坂　友博

分割表示 >> ／全件表示 80 件中 1 - 80 件目

エボカルセトにより加療した後天性低Ca尿性高Ca血症の一例

寺坂友博, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 佐々木恵里佳, 藤澤諭, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 100 ( Suppl.Update ) 15 - 18 2024年6月

記述言語：日本語出版者・発行元：(一社)日本内分泌学会

70歳代男性。小脳梗塞にて他院へ入院中、高Ca血症、intact PTH高値を認めたため、当院へ紹介となった。エボカルセトの投与によりPTHと血清Caの速やかな低下し、尿中Ca排泄の上昇がみられたが、休薬すると、PTHの著明な上昇、FECaの低下、血中Caの上昇を認めた。CaSR遺伝子解析では異常所見はみられなかったが、血清中に抗CaSR抗体が確認され、後天性低カルシウム尿性高カルシウム血症と診断された。外来にてエボカルセトの減量が行われたが、血中CaおよびPTHの変動が続くため、現在も投与を継続中である。

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2024&ichushi_jid=J01160&link_issn=&doc_id=20240705330005&doc_link_id=10.1507%2Fendocrine.100.S.Update_15&url=https%3A%2F%2Fdoi.org%2F10.1507%2Fendocrine.100.S.Update_15&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

甲状腺ホルモン不応症と遺伝性出血性毛細血管拡張症を合併した1例

森本栄作, 稲垣兼一, 石井貴大, 山岡主知, 佐々木恵里佳, 伊藤慶彦, 寺坂友博, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 100 ( Suppl.Update ) 31 - 32 2024年6月

PPGLのカテコールアミン産生に対するVandetanibの作用 PC12細胞を用いた検討

伊藤慶彦, 稲垣兼一, 山岡主知, 石井貴大, 森本栄作, 寺坂友博, 佐々木恵里佳, 藤澤諭, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 100 ( 1 ) 425 - 425 2024年5月

巨大な卵管膿瘍を合併して著明な口渇を伴うDiabetesの1例

藤澤諭, 稲垣兼一, 越智可奈子, 寺坂友博, 石井貴大, 山岡主知, 佐々木恵里佳, 伊藤慶彦, 森本栄作, 三好智子, 和田淳

日本内分泌学会雑誌 100 ( 1 ) 375 - 375 2024年5月

頭蓋内germinomaの診断を契機にKlinefelter症候群が明らかとなった成人例

森本栄作, 稲垣兼一, 石井貴大, 佐々木恵里佳, 伊藤慶彦, 藤澤諭, 寺坂友博, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 100 ( 1 ) 399 - 399 2024年5月

転移との鑑別を要した免疫チェックポイント阻害薬関連下垂体炎の1例

伊藤慶彦, 稲垣兼一, 山岡主知, 石井貴大, 佐々木恵里佳, 藤澤諭, 寺坂友博, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 4 ) 1055 - 1055 2024年1月

エボカルセトにより加療した後天性低Ca尿性高Ca血症の一例

寺坂友博, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 佐々木恵里佳, 藤澤諭, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 2 ) 567 - 567 2023年10月

甲状腺ホルモン不応症と遺伝性出血性毛細血管拡張症を合併した1例

森本栄作, 稲垣兼一, 山岡主知, 石井貴大, 佐々木恵里佳, 伊藤慶彦, 寺坂友博, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 2 ) 570 - 570 2023年10月

当院内分泌センターのVon Hippel-Lindau病患者の臨床的検討

佐々木恵里佳, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 藤澤諭, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 2 ) 624 - 624 2023年10月

後腹膜副腎部に発生したsolid pseudopapillary tumorの一例

石井貴大, 稲垣兼一, 山岡主知, 寺坂友博, 佐々木恵里佳, 伊藤慶彦, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 2 ) 622 - 622 2023年10月

甲状腺ホルモン不応症と遺伝性出血性毛細血管拡張症を合併した1例

森本栄作, 稲垣兼一, 山岡主知, 石井貴大, 佐々木恵里佳, 伊藤慶彦, 寺坂友博, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 2 ) 570 - 570 2023年10月

当院内分泌センターのVon Hippel-Lindau病患者の臨床的検討

佐々木恵里佳, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 藤澤諭, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 2 ) 624 - 624 2023年10月

エボカルセトにより加療した後天性低Ca尿性高Ca血症の一例

寺坂友博, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 佐々木恵里佳, 藤澤諭, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 2 ) 567 - 567 2023年10月

Retroperitoneal Solid Pseudopapillary Tumor Mimicking Adrenal Malignant Tumor in a 67-Year-Old Man

Takahiro Ishii, Tomohiro Terasaka, Kenji Nishida, Jun Wada

JCEM Case Reports 2023年7月

[The Tips of the Endocrine Assessment in the Case of Pituitary Tumor].

Tomohiro Terasaka, Kenichi Inagaki

No shinkei geka. Neurological surgery 51 ( 4 ) 625 - 633 2023年7月

記述言語：日本語掲載種別：研究論文（学術雑誌）

Pituitary tumors can cause an excess or deficiency of anterior pituitary hormones. Functional pituitary neuroendocrine tumors(PitNETs)include growth hormone(GH)-producing tumors, adrenocorticotropic hormone(ACTH)-producing tumors, thyroid-stimulating hormone(TSH)-producing tumors, and prolactin(PRL)-producing tumors. Comprehensive preoperative endocrine evaluation is essential for appropriate therapeutic decision-making and safe surgery. Here, we focus on the diagnosis and evaluation of PitNETs using endocrine function tests and intravascular catheterization for inferior petrosal sinus sampling for pituitary tumors.

DOI： 10.11477/mf.1436204795

COVID-19ワクチン接種を契機に診断した続発性副腎機能低下症の2例

宮崎貴裕, 稲垣兼一, 寺坂友博, 山岡主知, 石井貴大, 佐々木恵里佳, 伊藤慶彦, 西山悠紀, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 295 - 295 2023年5月

個別に発端者として診断され同一の病的バリアントを認めたMEN1型の4症例

佐々木恵里佳, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 藤澤諭, 寺坂友博, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 414 - 414 2023年5月

妊娠中期に摘出術を施行した原発性副甲状腺機能亢進症の1例

西山悠紀, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 佐々木恵里佳, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 386 - 386 2023年5月

RNA結合タンパクZFP36は下垂体ゴナドトロープLβT2細胞においてLH産生を制御する

寺坂友博, 藤澤諭, 宮崎貴裕, 伊藤慶彦, 森本栄作, 稲垣兼一, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 332 - 332 2023年5月

VandetanibのPPGLにおけるカテコールアミン合成及び細胞増殖に与える影響 PC12細胞を用いた検討

伊藤慶彦, 稲垣兼一, 森本栄作, 寺坂友博, 佐々木恵里佳, 藤澤諭, 西山悠紀, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 413 - 413 2023年5月

スクレロスチンとWnt-β-カテニン系がPPGLの病態に及ぼす影響 PC12細胞を用いた検討

森本栄作, 稲垣兼一, 小松原基志, 寺坂友博, 伊藤慶彦, 藤澤諭, 佐々木恵里佳, 西山悠紀, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 392 - 392 2023年5月

VandetanibのPPGLにおけるカテコールアミン合成及び細胞増殖に与える影響 PC12細胞を用いた検討

伊藤慶彦, 稲垣兼一, 森本栄作, 寺坂友博, 佐々木恵里佳, 藤澤諭, 西山悠紀, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 413 - 413 2023年5月

個別に発端者として診断され同一の病的バリアントを認めたMEN1型の4症例

佐々木恵里佳, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 藤澤諭, 寺坂友博, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 414 - 414 2023年5月

妊娠中期に摘出術を施行した原発性副甲状腺機能亢進症の1例

西山悠紀, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 佐々木恵里佳, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 386 - 386 2023年5月

GCM2新規変異を認めた家族性孤発性副甲状腺機能亢進症の1家系

森本栄作, 稲垣兼一, 西山悠紀, 佐々木恵里佳, 伊藤慶彦, 寺坂友博, 原孝行, 長谷川高誠, 志村和浩, 長谷川奉延, 和田淳

日本内分泌学会雑誌 99 ( Suppl.Update ) 36 - 37 2023年5月

スクレロスチンとWnt-β-カテニン系がPPGLの病態に及ぼす影響 PC12細胞を用いた検討

森本栄作, 稲垣兼一, 小松原基志, 寺坂友博, 伊藤慶彦, 藤澤諭, 佐々木恵里佳, 西山悠紀, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 392 - 392 2023年5月

COVID-19ワクチン接種を契機に診断した続発性副腎機能低下症の2例

宮崎貴裕, 稲垣兼一, 寺坂友博, 山岡主知, 石井貴大, 佐々木恵里佳, 伊藤慶彦, 西山悠紀, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 99 ( 1 ) 295 - 295 2023年5月

GCM2新規変異を認めた家族性孤発性副甲状腺機能亢進症の1家系

森本栄作, 稲垣兼一, 西山悠紀, 佐々木恵里佳, 伊藤慶彦, 寺坂友博, 原孝行, 長谷川高誠, 志村和浩, 長谷川奉延, 和田淳

日本内分泌学会雑誌 99 ( Suppl.Update ) 36 - 37 2023年5月

Lenvatinib内服中にネフローゼ症候群を発症し甲状腺ホルモン補充増量を要した甲状腺乳頭癌の1例

西山悠紀, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 佐々木恵里佳, 藤澤諭, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 5 ) 1302 - 1302 2023年3月

Lenvatinib内服中にネフローゼ症候群を発症し甲状腺ホルモン補充増量を要した甲状腺乳頭癌の1例

西山悠紀, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 佐々木恵里佳, 藤澤諭, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 5 ) 1302 - 1302 2023年3月

下大静脈に進展する巨大副腎腫瘍を認めたACTH依存性クッシング症候群の一例

佐々木恵里佳, 稲垣兼一, 藤澤諭, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 4 ) 1070 - 1070 2023年2月

下大静脈に進展する巨大副腎腫瘍を認めたACTH依存性クッシング症候群の一例

佐々木恵里佳, 稲垣兼一, 藤澤諭, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 4 ) 1070 - 1070 2023年2月

Effects of Wnt-β-Catenin Signaling and Sclerostin on the Phenotypes of Rat Pheochromocytoma PC12 Cells. 査読国際誌

Eisaku Morimoto, Kenichi Inagaki, Motoshi Komatsubara, Tomohiro Terasaka, Yoshihiko Itoh, Satoshi Fujisawa, Erika Sasaki, Yuki Nishiyama, Takayuki Hara, Jun Wada

Journal of the Endocrine Society 6 ( 10 ) bvac121 2022年10月

記述言語：英語掲載種別：研究論文（学術雑誌）

Pheochromocytomas and paragangliomas (PPGLs) are classified into 3 major categories with distinct driver genes: pseudohypoxia, kinase signaling, and Wnt-altered subtypes. PPGLs in the Wnt-altered subtype are sporadic and tend to be aggressive with metastasis, where somatic gene fusions affecting mastermind-like 3 (MAML3) and somatic mutations in cold shock domain containing E1 (CSDE1) cause overactivation of Wnt-β-catenin signaling. However, the relation between Wnt-β-catenin signaling and the biological behavior of PPGLs remains unexplored. In rat pheochromocytoma PC12 cells, Wnt3a treatment enhanced cell proliferation and suppressed mRNA expression of tyrosine hydroxylase (TH), the rate-limiting enzyme of catecholamine biosynthesis, and dopamine secretion. We identified the expression of sclerostin in PC12 cells, which is known as an osteocyte-derived negative regulator for Wnt signaling-driven bone formation. Inhibition of endogenous Wnt pathway by XAV939 or sclerostin resulted in attenuated cell proliferation and increased TH expression. Furthermore, Wnt3a pretreatment suppressed bone morphogenetic protein (BMP)-induced Smad1/5/9 phosphorylation whereas BMPs enhanced sclerostin expression in PC12 cells. In the Wnt-altered subtype, the increased Wnt-β-catenin pathway may contribute the aggressive clinical behavior with reduced catecholamine production. Furthermore, upregulated expression of sclerostin by BMPs may explain the osteolytic metastatic lesions observed in metastatic PPGLs.

DOI： 10.1210/jendso/bvac121

前立腺小細胞癌による異所性ACTH症候群の一例

佐々木恵里佳, 稲垣兼一, 藤澤諭, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 寺坂友博, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 613 - 613 2022年10月

GCM2新規変異を認めた家族性孤発性副甲状腺機能亢進症の1家系

森本栄作, 稲垣兼一, 西山悠紀, 佐々木恵里佳, 伊藤慶彦, 寺坂友博, 原孝行, 長谷川高誠, 志村和浩, 長谷川奉延, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 593 - 593 2022年10月

術前にバセドウ病を合併した下垂体腫瘤の3例

寺坂友博, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 佐々木恵里佳, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 567 - 567 2022年10月

アルコール多飲に伴うFGF23関連骨軟化症における鉄代謝の影響

西山悠紀, 稲垣兼一, 伊藤慶彦, 山岡主知, 石井貴大, 佐々木恵里佳, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 592 - 592 2022年10月

子宮筋腫を合併し妊娠中にPTHrP関連高Ca血症を反復した1例

伊藤慶彦, 稲垣兼一, 佐々木恵里佳, 藤澤諭, 西山悠紀, 森本栄作, 寺坂友博, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 556 - 556 2022年10月

前立腺小細胞癌による異所性ACTH症候群の一例

佐々木恵里佳, 稲垣兼一, 藤澤諭, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 寺坂友博, 森本栄作, 原孝行, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 613 - 613 2022年10月

子宮筋腫を合併し妊娠中にPTHrP関連高Ca血症を反復した1例

伊藤慶彦, 稲垣兼一, 佐々木恵里佳, 藤澤諭, 西山悠紀, 森本栄作, 寺坂友博, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 556 - 556 2022年10月

アルコール多飲に伴うFGF23関連骨軟化症における鉄代謝の影響

西山悠紀, 稲垣兼一, 伊藤慶彦, 山岡主知, 石井貴大, 佐々木恵里佳, 寺坂友博, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 592 - 592 2022年10月

術前にバセドウ病を合併した下垂体腫瘤の3例

寺坂友博, 稲垣兼一, 山岡主知, 石井貴大, 伊藤慶彦, 西山悠紀, 佐々木恵里佳, 森本栄作, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 567 - 567 2022年10月

GCM2新規変異を認めた家族性孤発性副甲状腺機能亢進症の1家系

森本栄作, 稲垣兼一, 西山悠紀, 佐々木恵里佳, 伊藤慶彦, 寺坂友博, 原孝行, 長谷川高誠, 志村和浩, 長谷川奉延, 和田淳

日本内分泌学会雑誌 98 ( 2 ) 593 - 593 2022年10月

褐色細胞腫/パラガングリオーマにおけるカテコラミン合成,細胞増殖に対するWnt-βカテニンシグナルの影響 PC12細胞を用いた検討

森本栄作, 稲垣兼一, 伊藤慶彦, 寺坂友博, 佐々木恵里佳, 藤澤諭, 西山悠紀, 原孝行, 越智可奈子, 三好智子, 和田淳

日本内分泌学会雑誌 98 ( 1 ) 381 - 381 2022年4月

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism. 査読国際誌

Natsumi Uchiyama-Matsuoka, Kenji Tsuji, Haruhito A Uchida, Shinji Kitamura, Yoshihiko Itoh, Yuki Nishiyama, Eisaku Morimoto, Satoshi Fujisawa, Tomohiro Terasaka, Takayuki Hara, Kanako Ogura-Ochi, Kenichi Inagaki, Jun Wada

Frontiers in endocrinology 13 1048863 - 1048863 2022年

記述言語：英語掲載種別：研究論文（学術雑誌）

INTRODUCTION: While it is well known that thyroid function may affect kidney function, the transition of the chronic kidney disease (CKD) status before and after treatment for thyroid disorders, as well as the factors affecting this change, remains to be explored. In the present study, we focused on the change in kidney function and their affecting factors during the treatment for both hyperthyroidism and hypothyroidism. METHODS: Eighty-eight patients with hyperthyroidism and fifty-two patients with hypothyroidism were enrolled in a retrospective and longitudinal case series to analyze the changes in kidney function and their affecting factors after treatment for thyroid disorders. RESULTS: Along with the improvement of thyroid function after treatment, there was a significant decrease in estimated glomerular filtration rate (eGFR) in hyperthyroidism (an average ΔeGFR of -41.1 mL/min/1.73 m2) and an increase in eGFR in hypothyroidism (an average ΔeGFR of 7.1 mL/min/1.73 m2). The multiple linear regression analysis revealed that sex, eGFR, free thyroxine (FT4) and free triiodothyronine (FT3) could be considered independent explanatory variables for ΔeGFR in hyperthyroidism, while age, eGFR, and FT3 were detected as independent explanatory variables in hypothyroidism. In addition, the stratification by kidney function at two points, pre- and post-treatment for thyroid disorders, revealed that 4.5% of the participants with hyperthyroidism were pre-defined as non-CKD and post-defined as CKD, indicating the presence of "masked" CKD in hyperthyroidism. On the other hand, 13.5% of the participants with hypothyroidism presented pre-defined CKD and post-defined non-CKD, indicating the presence of "reversible" CKD status in hypothyroidism. CONCLUSIONS: We uncovered the population of masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism, thereby re-emphasizing the importance of a follow-up to examine kidney function after treatment for hyperthyroidism and the routine evaluation of thyroid function in CKD patients as well as the appropriate hormone therapy if the patient has hypothyroidism.

DOI： 10.3389/fendo.2022.1048863

Androgen suppresses in vivo and in vitro LH pulse secretion and neural Kiss1 and Tac2 gene expression in female mice. 査読国際誌

Lourdes A Esparza, Tomohiro Terasaka, Mark A Lawson, Alexander S Kauffman

Endocrinology 2020年10月

記述言語：英語掲載種別：研究論文（学術雑誌）

Androgens can affect the reproductive axis of both sexes. In healthy (non-disease) women, as in men, elevated exogenous androgens decrease gonad function and lower gonadotropin levels; such circumstances occur with anabolic steroid abuse or in transgender men (genetic females identifying as males) taking androgen supplements. The neuroendocrine mechanisms by which endogenous or exogenous androgens regulate gonadotropin release, including aspects of pulsatile LH secretion, remain unknown. Because animal models are valuable for interrogating neural and pituitary mechanisms, we studied neuroendocrine effects of androgens in the normal male physiological range on both in vivo LH secretion parameters in female mice and in vitro LH secretion patterns from isolated female pituitaries. We also assessed androgen effects on hypothalamic and gonadotrope gene expression in females, which may contribute to altered LH secretion profiles. We used a non-aromatizable androgen, DHT, to isolate effects occurring specifically via androgen receptor (AR) signaling. Compared to control females, DHT-treated females exhibited markedly reduced in vivo LH pulsatility, with decreases in pulse frequency, amplitude, pulse peak, and basal LH levels. Correlating with reduced LH pulsatility, DHT-treated females also exhibited suppressed arcuate nucleus Kiss1 and Tac2 expression. Separate from these neural effects, we determined in vitro that the female pituitary is directly inhibited by AR signaling, resulting in lower basal LH levels and reduced LH secretory responses to GnRH pulses, along with lower gonadotropin gene expression. Thus, in normal adult females, male levels of androgen acting via AR can strongly inhibit the reproductive axis at both the neural and pituitary levels.

DOI： 10.1210/endocr/bqaa191

GLUT1-mediated glycolysis supports GnRH-induced secretion of luteinizing hormone from female gonadotropes. 査読国際誌

Dequina A Nicholas, Vashti S Knight, Karen J Tonsfeldt, Tomohiro Terasaka, Olivia Molinar-Inglis, Shannon B Z Stephens, JoAnn Trejo, Alexander S Kauffman, Pamela L Mellon, Mark A Lawson

Scientific reports 10 ( 1 ) 13063 - 13063 2020年8月

記述言語：英語掲載種別：研究論文（学術雑誌）

The mechanisms mediating suppression of reproduction in response to decreased nutrient availability remain undefined, with studies suggesting regulation occurs within the hypothalamus, pituitary, or gonads. By manipulating glucose utilization and GLUT1 expression in a pituitary gonadotrope cell model and in primary gonadotropes, we show GLUT1-dependent stimulation of glycolysis, but not mitochondrial respiration, by the reproductive neuropeptide GnRH. GnRH stimulation increases gonadotrope GLUT1 expression and translocation to the extracellular membrane. Maximal secretion of the gonadotropin Luteinizing Hormone is supported by GLUT1 expression and activity, and GnRH-induced glycolysis is recapitulated in primary gonadotropes. GLUT1 expression increases in vivo during the GnRH-induced ovulatory LH surge and correlates with GnRHR. We conclude that the gonadotropes of the anterior pituitary sense glucose availability and integrate this status with input from the hypothalamus via GnRH receptor signaling to regulate reproductive hormone synthesis and secretion.

DOI： 10.1038/s41598-020-69913-z

SRXN1 Is Necessary for Resolution of GnRH-Induced Oxidative Stress and Induction of Gonadotropin Gene Expression. 査読

Kim T, Li D, Terasaka T, Nicholas DA, Knight VS, Yang JJ, Lawson MA

Endocrinology 160 ( 11 ) 2543 - 2555 2019年11月

The RNA-Binding Protein ELAVL1 Regulates GnRH Receptor Expression and the Response to GnRH. 査読

Terasaka T, Kim T, Dave H, Gangapurkar B, Nicholas DA, Muñoz O, Terasaka E, Li D, Lawson MA

Endocrinology 160 ( 8 ) 1999 - 2014 2019年8月

Induction of Stress Signaling In Vitro and Suppression of Gonadotropin Secretion by Free Fatty Acids in Female Mouse Gonadotropes. 査読

Li S, Mbong EF, John DT, Terasaka T, Li D, Lawson MA

Endocrinology 159 ( 2 ) 1074 - 1087 2018年2月

Reactive Oxygen Species Link Gonadotropin-Releasing Hormone Receptor Signaling Cascades in the Gonadotrope 査読

Tomohiro Terasaka, Mary E. Adakama, Song Li, Taeshin Kim, Eri Terasaka, Danmei Li, Mark A. Lawson

FRONTIERS IN ENDOCRINOLOGY 8 286 2017年10月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：FRONTIERS MEDIA SA

Biological rhythms lie at the center of regulatory schemes that control many aspects of living systems. At the cellular level, meaningful responses to external stimuli depend on propagation and quenching of a signal to maintain vigilance for subsequent stimulation or changes that serve to shape and modulate the response. The hypothalamus-pituitary-gonad endocrine axis that controls reproductive development and function relies on control through rhythmic stimulation. Central to this axis is the pulsatile stimulation of the gonadotropes by hypothalamic neurons through episodic release of the neuropeptide gonadotropin-releasing hormone. Alterations in pulsatile stimulation of the gonadotropes result in differential synthesis and secretion of the gonadotropins LH and FSH and changes in the expression of their respective hormone subunit genes. The requirement to amplify signals arising from activation of the gonadotropin-releasing hormone (GnRH) receptor and to rapidly quench the resultant signal to preserve an adaptive response suggests the need for rapid activation and feedback control operating at the level of intracellular signaling. Emerging data suggest that reactive oxygen species (ROS) can fulfill this role in the GnRH receptor signaling through activation of MAP kinase signaling cascades, control of negative feedback, and participation in the secretory process. Results obtained in gonadotrope cell lines or other cell models indicate that ROS can participate in each of these regulatory cascades. We discuss the potential advantage of reactive oxygen signaling for modulating the gonadotrope response to GnRH stimulation and the potential mechanisms for this action. These observations suggest further targets of study for regulation in the gonadotrope.

DOI： 10.3389/fendo.2017.00286

Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein 査読

Kosuke Kimura, Tomohiro Terasaka, Nahoko Iwata, Takayuki Katsuyama, Motoshi Komatsubara, Ryota Nagao, Kenichi Inagaki, Fumio Otsuka

JOURNAL OF CLINICAL MEDICINE 6 ( 1 ) 2017年1月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：MDPI AG

Osteoblasts undergo differentiation in response to various factors, including growth factors and steroids. Bone mass is diminished in androgen- and/or growth hormone (GH)-deficient patients. However the functional relationship between androgen and GH, and their combined effects on bone metabolism, remains unclear. Here we investigated the mutual effects of androgen and GH on osteoblastic marker expression using mouse myoblastic C2C12 and osteoblast-like MC3T3-E1 cells. Combined treatment with dihydrotestosterone (DHT) and GH enhanced BMP-2-induced expression of Runx2, ALP, and osteocalcin mRNA, compared with the individual treatments in C2C12 cells. Co-treatment with DHT and GH activated Smad1/5/8 phosphorylation, Id-1 transcription, and ALP activity induced by BMP-2 in C2C12 cells but not in MC3T3-E1 cells. The insulin-like growth factor (IGF-I) mRNA level was amplified by GH and BMP-2 treatment and was restored by co-treatment with DHT in C2C12 cells. The mRNA level of the IGF-I receptor was not significantly altered by GH or DHT, while it was increased by IGF-I. In addition, IGF-I treatment increased collagen-1 mRNA expression, whereas blockage of endogenous IGF-I activity using an anti-IGF-I antibody failed to suppress the effect of GH and DHT on BMP-2-induced Runx2 expression in C2C12 cells, suggesting that endogenous IGF-I was not substantially involved in the underlying GH actions. On the other hand, androgen receptor and GH receptor mRNA expression was suppressed by BMP-2 in both cell lines, implying the existence of a feedback action. Collectively the results showed that the combined effects of androgen and GH facilitated BMP-2-induced osteoblast differentiation at an early stage by upregulating BMP receptor signaling.

DOI： 10.3390/jcm6010006

The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency 査読

Ko Harada, Kosuke Kimura, Masaya Iwamuro, Tomohiro Terasaka, Yoshihisa Hanayama, Eisei Kondo, Eiko Hayashi, Tadashi Yoshino, Fumio Otsuka

INTERNAL MEDICINE 56 ( 17 ) 2261 - 2269 2017年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：JAPAN SOC INTERNAL MEDICINE

Objective To analyze the clinical and endocrine characteristics of patients with primary adrenal lymphoma.
Patients We retrospectively reviewed the cases of five patients with primary adrenal lymphoma who were treated in our hospital between April 2004 and March 2015. We investigated the characteristics of the clinical and pathological findings, treatment, prognosis and complications of adrenal insufficiency.
Results Adrenal insufficiency, which was confirmed by the laboratory data at the initial presentation, was observed in two cases. One case was complicated by relative adrenal insufficiency during a course of chemotherapy. The plasma adrenaline and urinary adrenaline levels were decreased in four cases and three cases, respectively. Diffusion MRI was radiologically diagnostic. In all of the cases, the patients were pathologically diagnosed with diffuse large-B cell lymphoma and were treated with rituximab and CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone)-like chemotherapy. Two patients received central nervous system prophylaxis with high-dose methotrexate. Four of the patients survived and one patient died during the follow-up period.
Conclusion The early detection of adrenal insufficiency and the administration of an appropriate dose of hydrocortisone are necessary during the course of chemotherapy as well as at the initial manifestation. The exclusion of adrenal dysfunction prior to invasive diagnostic procedures, such as CT-guided needle biopsy, is also critical.

DOI： 10.2169/internalmedicine.8216-16

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn's disease 査読

Tomohiro Terasaka, Haruhito A. Uchida, Ryoko Umebayashi, Keiko Tsukamoto, Keiko Tanaka, Masashi Kitagawa, Hitoshi Sugiyama, Hiroaki Tanioka, Jun Wada

BMC NEPHROLOGY 17 ( 1 ) 122 2016年9月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：BIOMED CENTRAL LTD

Background: A link between IgA nephropathy and Crohn's disease has recently been reported. Other researchers hypothesize that intestine-derived IgA complexes deposit in glomerular mesangial cells, eliciting IgA nephropathy. Intestinal mucosal plasma cells mainly secrete IgA(2). Nevertheless, IgA(1) deposition is strongly implicated as being the primary cause of IgA nephropathy.
Case presentation: A 46-year-old Japanese man developed IgA nephropathy 29 years ago, following tonsillectomy. As a result, a normal urinalysis was obtained. The patient previously suffered Crohn's disease followed by urinary occult blood and proteinuria six years ago. Exacerbation of IgA nephropathy was highly suspected. Therefore a renal biopsy was performed. A diagnosis of exacerbation of IgA nephropathy with mesangial cell proliferation and fibrotic cellular crescent was based upon the pathological findings. The patient exhibited a positive clinical course and eventually achieved a remission with immunosuppressive therapy including prednisolone treatment. Immunostaining for the detection of IgA subtypes was performed on both of his kidney and excised ileum. The results revealed IgA(1) and IgA(2) deposition by submucosal cells in intestine. Furthermore, IgA(1) deposition of mesangial areas in the patient's kidney, indicated an association of IgA(1) with the exacerbation of IgA nephropathy.
Conclusion: This case represents the possibility that the intestine-derived IgA(1) can be the origin of galactose-deficient IgA which is known to cause IgA nephropathy exacerbation.

DOI： 10.1186/s12882-016-0344-1

A case of an adrenocorticotropic hormone-producing pituitary adenoma removed via electromagnetic-guided neuroendoscopy 査読

Yusuke Tomita, Kazuhiko Kurozumi, Tomohiro Terasaka, Kenichi Inagaki, Fumio Otsuka, Isao Date

Neurological Surgery 44 ( 6 ) 473 - 479 2016年6月

記述言語：日本語掲載種別：研究論文（学術雑誌）出版者・発行元：Igaku-Shoin Ltd

The use of navigation systems is safe and reliable for neurological surgery. We performed endoscopic transsphenoidal surgery to totally resect an adrenocorticotropic hormone (ACTH) -producing pituitary adenoma associated with oculomotor nerve palsy. A 70-year-old woman developed right ptosis 4 months before admission. She developed anisocoria 2 months later and was referred to the department of neurology from clinic. Brain magnetic resonance imaging (MR1) showed an intrasellar tumor that partially invaded the right cavernous sinus, and she was then referred to our department. She exhibited a round face ("moon face") and central obesity. Laboratory test results showed a high urinary Cortisol level and high serum ACTH level, and neither the serum Cortisol nor ACTH level was suppressed by a low-dose dexamethasone test. We performed transsphenoidal surgery using high-dimensional endoscopy under electromagnetic navigation. The tumor invading the cavernous sinus was visualized via endoscopy and confirmed on navigation using a flexible needle probe. Postoperative MRI showed total removal of the tumor, and the serum ACTH level recovered to the normal range. The patient's right oculomotor palsy resolved within 1 week postoperatively. In summary, electromagnetic navigation was useful for total resection of a pituitary tumor invading the cavernous sinus, contributing to normalization of the ACTH level and improvement in neurological symptoms.

DOI： 10.11477/mf.1436203313

BMP-6 modulates somatostatin effects on luteinizing hormone production by gonadrotrope cells 査読

Kishio Toma, Fumio Otsuka, Kohei Oguni, Tomohiro Terasaka, Motoshi Komatsubara, Naoko Tsukamoto-Yamauchi, Kenichi Inagaki, Hirofumi Makino

PEPTIDES 76 96 - 101 2016年2月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：ELSEVIER SCIENCE INC

The effects of somatostatin analogs and roles of BMP-6 in the regulation of luteinizing hormone (LH) secretion were investigated using mouse gonadotrope L beta T2 cells. LH mRNA expression and LH secretion induced by GnRH were suppressed by treatments with somatostatin analogs, including octreotide and pasireotide, in L beta T2 cells. Of note, the inhibitory effects of somatostatin analogs on LH secretion were enhanced by the action of BMP-6. BMP-6 increased the expression levels of somatostatin receptor (SSTR)5, suggesting that BMP-6 upregulates SSTR activity that leads to reduction of GnRH-induced LH secretion. In addition, GnRH-induced phosphorylation of MAPKs including ERK, but not P38 or SAPK, was suppressed by pasireotide in the presence of BMP-6. Given that each inhibitor of ERK, JNK or P38 signaling suppressed GnRH-induced LH transcription, MAPKs are individually involved in the induction of LH production by L beta T2 cells. Somatostatin analogs also impaired BMP-6-induced Smad1/5/8 phosphorylation by suppressing BMPRs and augmenting Smad6/7 expression. Collectively, the results indicate that somatostatin analogs have dual effects on the modulation of GnRH-induced MAPK signaling and BMP activity. The pituitary BMP system may play a regulatory role in GnRH-induced LH secretion by tuning the responsiveness to somatostatin analogs in gonadotrope cells. (C) 2016 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.peptides.2016.01.011

Invasive Intrasellar Plasmacytoma Mimicking Pituitary Adenoma 査読

Tomohiro Terasaka, Kenichi Inagaki, Fumio Otsuka

INTERNAL MEDICINE 55 ( 11 ) 1501 - 1502 2016年

White Feces Caused by the Administration of a Somatostatin Analogue 査読

Masaya Iwamuro, Tomohiro Terasaka, Fumio Otsuka, Hiroyuki Okada

INTERNAL MEDICINE 55 ( 13 ) 1817 - 1817 2016年

Pheochromocytoma Manifesting Persistent Right Shoulder Pain and Hypochondralgia

Hideharu Hagiya, Eri Nakamura, Tomohiro Terasaka, Kou Hasegawa, Kikuko Asano, Takahiro Nada, Kosuke Kimura, Koichi Waseda, Yoshihisa Hanayama, Fumio Otsuka

JOURNAL OF GENERAL AND FAMILY MEDICINE 16 ( 4 ) 292 - 296 2015年12月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：WILEY

We report a 42-year-old female who initially complained of sub-acute onset of right upper quadrant abdominal pain with right shoulder pain. A CT scan incidentally revealed an adrenal tumor, and a final diagnosis of pheochromocytoma was made on the basis of endocrinological examinations. Symptomatically, the pheochromocytoma in our patient mimicked a hepato-biliary disease by presenting abdominal pain accompanying right shoulder pain that was assumed to be referred pain via the right phrenic nerve. Physicians may need to consider the possibility of pheochromocytoma in patients with abdominal symptoms.

DOI： 10.14442/jgfm.16.4_292

Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2. 査読

Katsuyama T, Otsuka F, Terasaka T, Inagaki K, Takano-Narazaki M, Matsumoto Y, Sada KE, Makino H

Peptides 73 88 - 94 2015年11月

Mutual effects of melatonin and activin on induction of aldosterone production by human adrenocortical cells 査読

Takayuki Hara, Fumio Otsuka, Naoko Tsukamoto-Yamauchi, Kenichi Inagaki, Takeshi Hosoya, Eri Nakamura, Tomohiro Terasaka, Motoshi Komatsubara, Hirofumi Makino

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 152 8 - 15 2015年8月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD

Melatonin has been reported to suppress adrenocorticotropin (ACTH) secretion in the anterior pituitary and cortisol production in the adrenal by different mechanisms. However, the effect of melatonin on aldosterone production has remained unknown. In this study, we investigated the role of melatonin in the regulation of aldosterone production using human adrenocortical H295R cells by focusing on the activin system expressed in the adrenal. Melatonin receptor MT1 mRNA and protein were expressed in H295R cells and the expression levels of MT1 were increased by activin treatment. Activin increased ACTH-induced, but not angiotensin II (Ang II)-induced, aldosterone production. Melatonin alone did not affect basal synthesis of either aldosterone or cortisol. However, melatonin effectively enhanced aldosterone production induced by co-treatment with ACTH and activin, although melatonin had no effect on aldosterone production induced by Ang II in combination with activin. These changes in steroidogenesis became apparent when the steroid production was evaluated by the ratio of aldosterone/cortisol. Melatonin also enhanced dibutyryl-AMP-induced aldosterone/cortisol levels in the presence of activin, suggesting a functional link to the cAMP-PICA pathway for induction of aldosterone production by melatonin and activin. In accordance with the data for steroids, ACTH-induced, but not Ang II-induced, CAMP synthesis was also amplified by co-treatment with melatonin and activin. Furthermore, the ratio of ACTH-induced mRNA level of CYP11B2 compared with that of CYP17 was amplified in the condition of treatment with both rnelatonin and activin. In addition, melatonin increased expression of the activin type-I receptor ALK-4 but suppressed expression of inhibitory Smads6/7, leading to the enhancement of Smad2 phosphorylation. Collectively, the results showed that melatonin facilitated aldosterone production induced by ACTH and activin via the cAMP-PICA pathway. The results also suggested that mutual enhancement of melatonin and activin receptor signaling is involved in the induction of aldosterone output by adrenocortical cells. (C) 2015 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.jsbmb.2015.04.012

A Paraganglioma in a Hypertensive Patient with Unilateral Renal Hypoplasia 査読

Tomohiro Terasaka, Hideharu Hagiya, Kosuke Kimura, Takahiro Nada, Eri Nakamura, Yoshihisa Hanayama, Hitoshi Sugiyama, Yasuyuki Kobayashi, Hiroyuki Yanai, Fumio Otsuka

ACTA MEDICA OKAYAMA 69 ( 2 ) 119 - 122 2015年4月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：OKAYAMA UNIV MED SCHOOL

We report the case of a 46-year-old hypertensive Japanese female with renal insufficiency related to unilateral renal hypoplasia. The patient was found to have developed paraganglioma in the retroperitoneal space over a 5-year period. Catecholamine-producing tumors are not usually recognized as conditions associated with renal hypoplasia. Our long-term observation of the patient eventually led us to the diagnosis of paraganglioma. In hypertensive patients with chronic kidney disease, not only the renin-angiotensin-aldosterone system but also catecholamine activity may be involved, particularly in the patients whose cases are complicated with unilateral renal hypoplasia.

DOI： 10.18926/AMO/53341

Complication of chronic eosinophilic pneumonia in an elderly patient with Sjögren syndrome. 査読

Waseda K, Hagiya H, Hanayama Y, Terasaka T, Kimura K, Tsuzuki T, Hasegawa K, Nada T, Nakamura E, Murakami K, Kondo E, Otsuka F

Acta medica Okayama 69 ( 2 ) 123 - 127 2015年4月

Regulatory role of BMP-9 in steroidogenesis by rat ovarian granulosa cells 査読

Takeshi Hosoya, Fumio Otsuka, Eri Nakamura, Tomohiro Terasaka, Kenichi Inagaki, Naoko Tsukamoto-Yamauchi, Takayuki Hara, Kishio Toma, Motoshi Komatsubara, Hirofumi Makino

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 147 85 - 91 2015年3月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD

BMPs expressed in the ovary differentially regulate steroidogenesis by granulosa cells. BMP-9, a circulating BMP, is associated with cell proliferation, apoptosis and differentiation in various tissues. However, the effects of BMP-9 on ovarian function have yet to be elucidated. Here we investigated BMP-9 actions on steroidogenesis using rat primary granulosa cells. BMP-9 potently suppressed FSH-induced progesterone production, whereas it did not affect FSH-induced estradiol production by granulosa cells. The effects of BMP-9 on FSH-induced steroidogenesis were not influenced by the presence of oocytes. FSH-induced cAMP synthesis and FSH-induced mRNA expression of steroidogenic factors, including StAR, P450scc, 3 beta HSD2 and FSHR, were suppressed by treatment with BMP-9. BMP-9 mRNA expression was detected in granulosa cells but not in oocytes. BMP-9 readily activated Smad1/5/8 phosphorylation and Id-1 transcription in granulosa cells. Analysis using ALK inhibitors indicated that BMP-9 actions were mediated via type-I receptors other than ALK-2, -3 and -6. Furthermore, experiments using extracellular domains (ECDs) for BMP type-I and -II receptor constructs revealed that the effects of BMP-9 were reversed by ECDs for ALK-1 and BMPRII. Thus, the functional receptors for BMP-9 in granulosa cells were most likely to be the complex of ALK-1 and BMPRII. Collectively, the results of the present study showed that BMP-9 can affect luteinization and that there are two possible sources of BMP-9, serum and granulosa cells in the ovary. (C) 2014 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.jsbmb.2014.12.007

Interaction of pituitary hormones and expression of clock genes modulated by bone morphogenetic protein-4 and melatonin 査読

Naoko Tsukamoto-Yamauchi, Tomohiro Terasaka, Yasumasa Iwasaki, Fumio Otsuka

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 459 ( 1 ) 172 - 177 2015年3月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：ACADEMIC PRESS INC ELSEVIER SCIENCE

Functional interaction of clock genes and pituitary hormones was investigated by focusing on bone morphogenetic protein (BMP)-4 and melatonin actions in anterior pituitary cells. A significant correlation between the mRNA expression of proopiomelanocortin (POMC) and Per2 was revealed in serial cultures of corticotrope AtT20 cells. Knockdown of Per2 expression by siRNA in AtT20 cells resulted in a significant reduction of POMC mRNA level with or without corticotropin-releasing hormone (CRH) stimulation. Treatments with BMP-4 and melatonin, both of which suppress POMC expression, reduced Per2 mRNA as well as protein levels in AtT20 cells. On the other hand, in lactosomatotrope GH3 cells, an expressional correlation was found between prolactin (PRL) and Clock mRNA levels, which was attenuated in the presence of forskolin treatment. The siRNA-mediated knockdown of Clock expression, but not that of Bmal1, significantly reduced PRL mRNA levels in GH3 cells. Interestingly, Clock mRNA and protein levels did not fluctuate with melatonin, BMP-4 or forskolin treatment, although Small expression was significantly increased by forskolin treatment. Collectively, a significant correlation between the expression of POMC and Per2 and that. between PRL and Clock were uncovered in corticotrope and lactosomatotrope cells, respectively. Per2 expression was inhibited by POMC modulators including melatonin and BMP-4, while Clock expression was steadily maintained. Thus, the effects of melatonin and BMP-4 on clock gene expression may imply differential stability of circadian rhythms of adrenocorticotropin (ACTH) and PRL secreted from the anterior pituitary. (C) 2015 Elsevier Inc. All rights reserved.

DOI： 10.1016/j.bbrc.2015.02.100

Myopathy and Eosinophilic Pneumonia Coincidentally Induced by Treatment with Daptomycin 査読

Hideharu Hagiya, Kou Hasegawa, Kikuko Asano, Tomohiro Terasaka, Kosuke Kimura, Takahiro Nada, Eri Nakamura, Koichi Waseda, Yoshihisa Hanayama, Fumio Otsuka

INTERNAL MEDICINE 54 ( 5 ) 525 - 529 2015年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：JAPAN SOC INTERNAL MEDICINE

A 34-year-old man with 22q11.2 deletion syndrome (DiGeorge syndrome) concurrently suffered from myopathy and eosinophilic pneumonia shortly after receiving daptomycin (DAP) for right-sided infective endocarditis. The simultaneous occurrence of these phenomena in relation to DAP therapy has not been previously well described. An allergic reaction was suspected as a possible etiology of these DAP-related complications. This case highlights the need for close observation in order to detect both musculoskeletal and respiratory disorders from the start of DAP therapy. Physicians should pay more attention to this new drug, which is expected to be frequently used in various clinical settings.

DOI： 10.2169/internalmedicine.54.3397

An Insulinoma Discovered in a Patient with Diffusely Calcified Chronic Pancreatitis 査読

Tomohiro Terasaka, Keiko Tsukamoto, Kenichi Inagaki, Fumio Otsuka

INTERNAL MEDICINE 54 ( 21 ) 2785 - 2786 2015年

Aortic vascular graft infection caused by Cardiobacterium valvarum: A case report 査読

Hideharu Hagiya, Susumu Kokeguchi, Hiroko Ogawa, Tomohiro Terasaka, Kosuke Kimura, Koichi Waseda, Yoshihisa Hanayama, Kaori Oda, Hisatoshi Mori, Toru Miyoshi, Fumio Otsuka

JOURNAL OF INFECTION AND CHEMOTHERAPY 20 ( 12 ) 804 - 809 2014年12月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：SPRINGER JAPAN KK

A 53-year-old man with a past medical history of total arch replacement surgery and severe aortic regurgitation presented with a 1-month history of persistent general malaise, anorexia, body weight loss and night sweats. His recent history included gingival hyperplasia for 6 years, gingivitis after tooth extraction 3 years before, prolonged inflammatory status for 4 months, fundal hemorrhage and leg tenderness for 2 months. A pathogen was detected from blood culture, but conventional microbiological examination failed to identify the pathogen. The organism was eventually identified as Cardiobacterium valvarum by 16S rRNA analysis, and the patient was diagnosed with infective endocarditis and prosthetic vascular graft infection. The patient received intravenous antibiotic therapy using a combination of ceftriaxone and levofloxacin for 5 weeks and was discharged with a good clinical course.
C. valvarum is a rare human pathogen in clinical settings. Only 10 cases have been reported to date worldwide, and therefore, the clinical characteristics of C. valvarum infection are not fully known. This is a first well-described case of C. valvarum infection in Japan, and further, a first report of aortic prosthetic vascular graft infection worldwide. Identification of C. valvarum is usually difficult due to its phenotypic characteristics, and molecular approaches would be required for both clinicians and microbiologists to facilitate more reliable diagnosis and uncover its clinical picture more clearly. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.jiac.2014.07.008

Melatonin counteracts BMP-6 regulation of steroidogenesis by rat granulosa cells 査読

Eri Nakamura, Fumio Otsuka, Tomohiro Terasaka, Kenichi Inagaki, Takeshi Hosoya, Naoko Tsukamoto-Yamauchi, Kishio Toma, Hirofumi Makino

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 143 233 - 239 2014年9月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：PERGAMON-ELSEVIER SCIENCE LTD

The ovarian bone morphogenetic protein (BMP) system is a physiological inhibitor of luteinization in growing ovarian follicles. BMP-6, which is expressed in oocytes and granulosa cells of healthy follicles, specifically inhibits FSH actions by suppressing adenylate cyclase activity. In the present study, we studied the role of melatonin in ovarian steroidogenesis using rat primary granulosa cells of immature female rat ovaries by focusing on the interaction with BMP-6 activity. Treatment with melatonin had no direct effect on FSH-induced progesterone or estradiol production by granulosa cells, and the results were not affected by the presence of co-cultured oocytes. In addition, synthesis of CAMP by granulosa cells was not significantly altered by melatonin treatment. To elucidate the interaction between activities of melatonin and BMPs, the effect of melatonin treatment on suppression of progesterone synthesis by BMP-6 was investigated. Interestingly, the inhibitory effect of BMP-6 on FSH-induced progesterone production was impaired by co-treatment with melatonin. Granulosa cells express higher levels of MT1 than MT2, and BMP-6 had no significant effect on MT1 expression in granulosa cells. However, BMP-6-induced Smad1/5/8 phosphorylation and Id-1 transcription were suppressed by melatonin, suggesting that melatonin has an inhibitory effect on BMP receptor signaling in granulosa cells. Although the expression levels of ALK-2, -6, ActRII and BMPRII were not affected by melatonin, inhibitory Smad6, but not Smad7, expression was upregulated by melatonin. Thus, melatonin plays a role in the regulation of BMP-6 signal intensity for controlling progesterone production in the ovary. These findings suggest that the effect of melatonin on maintenance of ovarian function is, at least in part, due to the regulation of endogenous BMP activity in granulosa cells. (C) 2014 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.jsbmb.2014.04.003

Retroperitoneal bronchogenic cyst: a rare incidentaloma discovered in a juvenile hypertensive patient 査読

Tomohiro Terasaka, Fumio Otsuka, Kanako Ogura-Ochi, Tomoko Miyoshi, Kenichi Inagaki, Yasuyuki Kobayashi, Yasutomo Nasu, Hirofumi Makino

HYPERTENSION RESEARCH 37 ( 6 ) 595 - 597 2014年6月

Long-term Observation of Osteomalacia Caused by Adefovir-Induced Fanconi's Syndrome 査読

Tomohiro Terasaka, Eijiro Ueta, Hirotaka Ebara, Koichi Waseda, Yoshihisa Hanayama, Akinobu Takaki, Tomoko Kawabata, Hitoshi Sugiyama, Ko Hidani, Fumio Otsuka

ACTA MEDICA OKAYAMA 68 ( 1 ) 53 - 56 2014年2月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：OKAYAMA UNIV MED SCHOOL

A 64-year-old man suffering polyarthralgia and bone pain was referred to our hospital. Renal dysfunction, hypophosphatemia and increased levels of bone alkaline phosphatase were found. The patient's serum creatinine level had gradually increased after the initiation of adefovir dipivoxil administration for hepatitis B. In agreement with multifocal uptakes of bone scintigraphy, iliac bone biopsy revealed an abnormal increase in osteoid tissues. Reducing the dose of adefovir and initiating the administration of eldecalcitol were effective for reducing proteinuria and glucosuria, and for ameliorating bone pain with an increase in serum phosphate level. This case first showed a clinical course of hypophosphatemic osteomalacia caused by secondary Fanconi's syndrome for 8 years after adefovir administration. Early diagnosis is important for the reversibility of bone damage and for a better renal prognosis.

DOI： 10.18926/AMO/52145

Fosfomycin for the Treatment of Prostate Infection 査読

Hideharu Hagiya, Megumi Ninagawa, Kou Hasegawa, Tomohiro Terasaka, Kosuke Kimura, Koichi Waseda, Yoshihisa Hanayama, Toshiaki Sendo, Fumio Otsuka

INTERNAL MEDICINE 53 ( 22 ) 2643 - 2646 2014年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：JAPAN SOC INTERNAL MEDICINE

A 69-year-old man with diabetes mellitus was diagnosed with a prostate abscess. Although the pathogen was fluoroquinolone-resistant Escherichia coli and the oral administration of trimethoprim-sulfamethoxazole was initiated, the infection recurred after three months. The antibiotic therapy was subsequently changed to intravenous fosfomycin, and the patient's condition promptly improved. Four weeks of fosfomycin therapy was successfully continued without any adverse events. In the era of antibiotic resistance, revival of forgotten drugs is an important issue for clinicians. Fosfomycin can be applied as an alternative option for prostate infections, considering the remaining susceptibility of multidrug-resistant pathogens to fosfomycin and the good pharmacokinetics of this drug in prostatic tissue.

DOI： 10.2169/internalmedicine.53.3098

Filarial Chyluria as a Rare Cause of Urinary Retention 査読

Hideharu Hagiya, Tomohiro Terasaka, Kosuke Kimura, Asuka Satou, Kikuko Asano, Koichi Waseda, Yoshihisa Hanayama, Takahide Takahashi, Michinori Aoe, Koji Iio, Toshiyuki Watanabe, Eisei Kondo, Fumio Otsuka

INTERNAL MEDICINE 53 ( 17 ) 2001 - 2005 2014年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：JAPAN SOC INTERNAL MEDICINE

We herein describe a case of Wuchereria bancrofti infection in a previously healthy 37-year-old Nepalese man. The patient presented with a history of milky urine with subsequent acute urinary retention lasting for a few days. The presence of microfilariae was confirmed on both peripheral blood and urine smears obtained at midnight. He was conservatively treated with diethylcarbamazine combined with doxycycline. Filariasis was previously endemic in southern parts of Japan, although it has been eradicated. Clinicians should remember filariasis as a potential etiology of urinary retention, especially in cases that may be associated with imported infectious disease.

DOI： 10.2169/internalmedicine.53.2572

Recurrent Stenotrophomonas maltophilia Bacteremia after Iliac Crest Bone Graft Harvest 査読

Hideharu Hagiya, Hiroko Ogawa, Tomoharu Ishida, Tomohiro Terasaka, Kosuke Kimura, Koichi Waseda, Yoshihisa Hanayama, Masahiro Horita, Yasunori Shimamura, Eisei Kondo, Fumio Otsuka

INTERNAL MEDICINE 53 ( 15 ) 1693 - 1698 2014年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：JAPAN SOC INTERNAL MEDICINE

We describe a rare case of recurrent Stenotrophomonas maltophilia bacteremia in a previously healthy 45-year-old man. The infection was caused by osteomyelitis at the site of an iliac crest bone graft harvest. A genetic analysis using enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) revealed that the blood isolates and pathogens obtained from the surgical wound were identical. Initial treatment with levofloxacin and cefozopran was ineffective, but the patient's infection was successfully treated by long-term administration of latamoxef and trimethoprim-sulfamethoxazole. The present case suggests that attention should be given to the possibility of S. maltophilia infection in any situations.

DOI： 10.2169/internalmedicine.53.1995

Successful Treatment of Persistent MRSA Bacteremia using High-dose Daptomycin Combined with Rifampicin 査読

Hideharu Hagiya, Tomohiro Terasaka, Kosuke Kimura, Asuka Satou, Kikuko Asano, Koichi Waseda, Yoshihisa Hanayama, Fumio Otsuka

INTERNAL MEDICINE 53 ( 18 ) 2159 - 2163 2014年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：JAPAN SOC INTERNAL MEDICINE

We herein report a case of persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia that was successfully treated with combination therapy consisting of high-dose daptomycin (DAP, 10 mg/kg) and rifampicin. The patient's condition was complicated with multiple infectious foci, including an iliopsoas abscess and epidural abscess, as well as discitis and spondylitis at the cervical, thoracic and lumbar levels. Monotherapy treatments with vancomycin, linezolid and usual-dose DAP were all ineffective. It has been shown that usual-dose DAP administration may result in the emergence of a resistant strain and treatment failure. We would like to emphasize the importance of high-dose DAP therapy for MRSA bacteremia, a condition with a potentially high mortality rate.

DOI： 10.2169/internalmedicine.53.2711

Mutual interaction of kisspeptin, estrogen and bone morphogenetic protein-4 activity in GnRH regulation by GT1-7 cells 査読

Tomohiro Terasaka, Fumio Otsuka, Naoko Tsukamoto, Eri Nakamura, Kenichi Inagaki, Kishio Toma, Kanako Ogura-Ochi, Christine Glidewell-Kenney, Mark A. Lawson, Hirofumi Makino

MOLECULAR AND CELLULAR ENDOCRINOLOGY 381 ( 1-2 ) 8 - 15 2013年12月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：ELSEVIER IRELAND LTD

Reproduction is integrated by interaction of neural and hormonal signals converging on hypothalamic neurons for controlling gonadotropin-releasing hormone (GnRH). Kisspeptin, the peptide product of the kiss1 gene and the endogenous agonist for the GRP54 receptor, plays a key role in the regulation of GnRH secretion. In the present study, we investigated the interaction between kisspeptin, estrogen and BMPs in the regulation of GnRH production by using mouse hypothalamic GT1-7 cells. Treatment with kisspeptin increased GnRH mRNA expression and GnRH protein production in a concentration-dependent manner. The expression levels of kiss1 and GPR54 were not changed by kisspeptin stimulation. Kisspeptin induction of GnRH was suppressed by co-treatment with BMPs, with BMP-4 action being the most potent for suppressing the kisspeptin effect. The expression of kisspeptin receptor, GPR54, was suppressed by BMPs, and this effect was reversed in the presence of kisspeptin. It was also revealed that BMP-induced Smad1/5/8 phosphorylation and Id-1 expression were suppressed and inhibitory Smad6/7 was induced by kisspeptin. In addition, estrogen induced GPR54 expression, while kisspeptin increased the expression levels of ER alpha. and ER beta, suggesting that the actions of estrogen and kisspeptin are mutually enhanced in GT1-7 cells. Moreover, kisspeptin stimulated MAPKs and AKT signaling, and ERK signaling was functionally involved in the kisspeptin-induced GnRH expression. BMP-4 was found to suppress kisspeptin-induced GnRH expression by reducing ERK signaling activity. Collectively, the results indicate that the axis of kisspeptin-induced GnRH production is bi-directionally controlled, being augmented by an interaction between ER alpha/beta and GPR54 signaling and suppressed by BMP-4 action in GT1-7 neuron cells. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.mce.2013.07.009

Melatonin receptor activation suppresses adrenocorticotropin production via BMP-4 action by pituitary AtT20 cells 査読

Naoko Tsukamoto, Fumio Otsuka, Kanako Ogura-Ochi, Kenichi Inagaki, Eri Nakamura, Kishio Toma, Tomohiro Terasaka, Yasumasa Iwasaki, Hirofumi Makino

MOLECULAR AND CELLULAR ENDOCRINOLOGY 375 ( 1-2 ) 1 - 9 2013年8月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：ELSEVIER IRELAND LTD

The role of melatonin, a regulator of circadian rhythm, in adrenocorticotropin (ACTH) production by corticotrope cells has not been elucidated. In this study, we investigated the effect of melatonin on ACTH production in relation to the biological activity of bone morphogenetic protein (BMP)-4 using mouse corticotrope AtT20 cells that express melatonin type-1 (MT1R) but not type-2 (MT2R) receptors. We previously reported that BMP-4 inhibits corticotropin-releasing hormone (CRH)-induced ACTH production and proopiomelanocortin (POMC) transcription by inhibiting MAPK signaling. Both melatonin and an MT1R/MT2R agonist, ramelteon, suppressed CRH-induced ACTH production, POMC transcription and cAMP synthesis. The inhibitory effects of ramelteon on basal and CRH-induced POMC mRNA and ACTH levels were more potent than those of melatonin. Treatment with melatonin or ramelteon in combination with BMP-4 additively suppressed CRH-induced ACTH production. Of note, the level of MTIR expression was upregulated by BMP-4 stimulation. The suppressive effects of melatonin and ramelteon on POMC transcription and cAMP synthesis induced by CRH were not affected by an MT2R antagonist, luzindole. On the other hand, BMP-4-induced Smad1/5/8 phosphorylation and the expression of a BMP target gene, Id-1, were augmented in the presence of melatonin and ramelteon. Considering that the expression levels of BMP receptors, ALK-3/BMPRII, were increased by ramelteon, MTIR action may play an enhancing role in BMP-receptor signaling. Among the MTIR signaling pathways including AKT, ERK and JNK pathways, inhibition of AKT signaling functionally reversed the MT1R effects on both CRH-induced POMC transcription and BMP-4-induced Id-1 transcription. Collectively, MT1R signaling and BMP-4 actions were mutually augmented, leading to fine-tuning of ACTH production by corticotrope cells. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.mce.2013.05.010

Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells 査読

Naoko Tsukamoto, Fumio Otsuka, Tomoko Miyoshi, Kenichi Inagaki, Eri Nakamura, Tomohiro Terasaka, Masaya Takeda, Toshio Ogura, Yasumasa Iwasaki, Hirofumi Makino

MOLECULAR AND CELLULAR ENDOCRINOLOGY 344 ( 1-2 ) 41 - 50 2011年9月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：ELSEVIER IRELAND LTD

Mechanisms by which GHRP stimulates ACTH release in corticotrope cells were investigated using mouse corticotrope AtT20 cells by focusing on the biological activity of BMP-4. GHRP-2 increased ACTH and cAMP secretion by AtT20 cells; however, its effects were less potent than the effects of CRH. BMP-4 suppressed basal ACTH production and POMC transcription, and the inhibition of endogenous BMP receptor signaling led to an increase in ACTH production. Of note, BMP-4 suppressed ACTH production and POMC-promoter activity induced by CRH more efficaciously than that induced by GHRP-2. BMP-4 had no significant effect on cAMP synthesis induced by CRH or GHRP-2. Stimulation with CRH, but not GHRP-2, activated ERK1/2, p38, SAPK/JNK and Akt phosphorylation, in which CRH-induced phosphorylation of ERR and p38 was suppressed by BMP-4. GHRP-2-induced ACTH secretion was not affected by inhibitors of ERR, p38 and Akt pathways, which effectively suppressed CRH-induced ACTH release. Blockage of the cAMP-PKA pathway reversed CRH- as well as GHRP-2-induced ACTH secretion. Furthermore, the inhibition of ERR and p38 significantly reduced cAMP synthesis induced by CRH but not by GHRP-2. Thus, CRH activates ACTH production through ERR and p38 pathways in addition to the cAMP-PKA pathway, which is also activated downstream of MAPK. On the other hand, GHRP-2-induced ACTH production was predominantly linked to the cAMP-PKA pathway. Moreover, CRH and GHRP-2 upregulated BMP receptor signaling, while BMP-4, CRH and GHRP-2 had no significant effect on the expression level of GHSR. In addition, GHRP-2 suppressed the expression of Smad7, which is an inhibitor of the BMP-Smad1/5/8 pathway. Collectively, the results revealed a functional interaction between GHRP-2 and BMP signaling, in which endogenous BMP may act as an autoregulatory system in controlling ACTH production. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

DOI： 10.1016/j.mce.2011.06.016

Regulation of GNRH production by estrogen and bone morphogenetic proteins in GT1-7 hypothalamic cells 査読

Hiroyuki Otani, Fumio Otsuka, Masaya Takeda, Tomoyuki Mukai, Tomohiro Terasaka, Tomoko Miyoshi, Kenichi Inagaki, Jiro Suzuki, Toshio Ogura, Mark A. Lawson, Hirofumi Makino

JOURNAL OF ENDOCRINOLOGY 203 ( 1 ) 87 - 97 2009年10月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：BIOSCIENTIFICA LTD

Recent studies have shown that bone morphogenetic proteins (BMPs) are important regulators in the pituitary-gonadal endocrine axis. We here investigated the effects of BMPs on GNRH production controlled by estrogen using murine GT1-7 hypothalamic neuron cells. GT1-7 cells expressed estrogen receptor alpha (ER alpha; ESR1 as listed in MGI Database), ER beta (ESR2 as listed in MGI Database), BMP receptors, SMADs, and a binding protein follistatin. Treatment with BMP2 and BMP4 had no effect on Gnrh mRNA expression; however, BMP6 and BMP7 significantly increased Gnrh mRNA expression as well as GnRH production by GT1-7 cells. Notably, the reduction of Gnrh expression caused by estradiol (E(2)) was restored by cotreatment with BMP2 and BMP4, whereas it was not affected by BMP6 or BMP7. E(2) activated extracellular signal-regulated kinase (ERK) 1/2 and stress-activated protein kinase/c-Jun NH(2)-terminal kinase (SAPK/JNK) signaling but did not activate p38-mitogen-activated protein kinase (MAPK) signaling in GT1-7 cells. Inhibition of ERK1/ERK2 reversed the inhibitory effect of estrogen on Gnrh expression, whereas SAPK/JNK inhibition did not affect the E(2) actions. Expression levels of Era and Er beta were reduced by BMP2 and BMP4, but were increased by BMP6 and BMP7. Treatment with an ER antagonist inhibited the E, effects on Gnrh suppression including reduction of E(2)-induced ERK phosphorylation, suggesting the involvement of genomic ER actions in Gnrh suppression. BMP2 and BMP4 also suppressed estrogen-induced phosphorylation of ERK1/ERK2 and SAPK/JNK signaling, suggesting that BMP2 and BMP4 downregulate estrogen effects by attenuating ER-MAPK. signaling. Considering that BMP6 and BMP7 increased the expression of alpha 1E-subunit of R-type calcium channel (Cacna1e), which is critical for GNRH secretion, it is possible that BMP6 and BMP7 directly stimulate GNRH release by GT1-7 cells. Collectively, a newly uncovered interaction of BMPs and ER may be involved in controlling hypothalamic GNRH production and secretion via an autocrine/paracrine mechanism. Journal of Endocrinology (2009) 203, 87-97

DOI： 10.1677/JOE-09-0065

Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion 査読

Jiro Suzuki, Fumio Otsuka, Kenichi Inagaki, Hiroyuki Otani, Tomoko Miyoshi, Tomohiro Terasaka, Toshio Ogura, Masako Omori, Yasutomo Nasu, Hirofumi Makino

HYPERTENSION RESEARCH 30 ( 4 ) 367 - 373 2007年4月

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：JAPANESE SOC HYPERTENSION CENT ACADEMIC SOC, PUBL OFFICE

A 35-year-old Japanese woman was referred for further examination of persistent hypertension with hypokalemia. Her serum aldosterone levels were high and her plasma renin activity markedly suppressed. Radiological examinations revealed the presence of a 3-cm diameter left adrenal tumor. I-131-adosterol was specifically accumulated in the left adrenal tumor, whereas the accumulation in the right adrenal was completely suppressed. Low-dose dexamethasone failed to suppress cortisol secretion although the serum cortisol levels were within the normal range. Urinary excretion of 17-hydroxycorticosteroids but not 17-ketosteroids was increased. Levels of plasma adrenocorticotropin (ACTH) and serum dehydroepiandrosterone sulfate (DHEAS) were decreased. Upon diagnosis of left aldosteronoma with autonomous secretion of cortisol, left adrenalectomy was performed by laparoscopy. In the resected adenoma tissues, clear cells expressed P450c17 protein and the ratio of CYP17/CYP11B2 mRNA evaluated by quantitative real-time polymerase chain reaction (PCR) was apparently higher than that of typical aldosteronomas. Based on the corticotropin-releasing hormone (CRH) loading tests, the contra-lateral adrenal functions were restored 3 months after surgery. These results indicate that evaluation for autonomy of cortisol secretion and contralateral adrenal function is clinically important to avoid the risk of adrenal failure after surgery for primary aldosteronism.

DOI： 10.1291/hypres.30.367

　前のページ - 次のページ　

1